Kennedy Jr. is part of President-elect Donald Trump‘s transition team, how should investors think about his potential ...

Big Data, Real World, Multi-State Study Finds RSV Vaccine Highly Effective in Protecting Older Adults Against Severe Disease, Hospitalization and Death Oct. 17, 2024 — This multi-state study is ...

while some current vaccines are only modestly effective against their target germ, like the seasonal flu shot. There’s only so much time and resources that can be devoted to developing vaccines ...

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

Doctors detail what we learned after the first season following the approval of RSV vaccines. The vaccine effectively prevented severe illness in older, but only 24 percent of eligible US adults ...

The Centers for Disease Control and Prevention now recommends that people ages 65 and up and those with weakened immune ...

Trump obviously doesn’t need a phalanx of voices online and on TV to spread false claims. But his campaign and his victory ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

While the inquiry gets most things right, as vaccine experts, we argue the government response should be broadened in three ...

With the election of former President Donald Trump, CEOs need to reassess how the companies they lead should contribute to ...

Studies have shown these vaccines to be effective, with the Pfizer, GSK, and Moderna vaccines preventing RSV pneumonia and bronchitis in more than 80% of participants. A recent study published in ...